Steven Eisenberg, DO, a San Diego-based oncologists at California Care Associates for Research & Excellence, has a passion for singing and songwriting, which he shares with patients and with the world.
Editor's Pick
Jessica Vanhouten started her own Dungeons & Dragons dice business because she wanted more and more custom dice for role playing games, but the skills she learned there led her to a job finishing dentures in a Wisconsin dental lab.
March is Kidney Cancer Awareness month and a good time to reflect on recent advancements in the treatment of patients with renal cell carcinoma. Recent years have brought numerous new therapies and combination regimens to this space, with breakthrough research ongoing. Following the recent 2022 Genitourinary Cancers Symposium, Chung-Han Lee, MD, PhD, Daniel M. Geynisman, MD, and Toni K. Choueiri, MD, spoke with editors at CancerNetwork® to discuss recent advances that have the potential to significantly impact care and ongoing trials that clinicians should be aware of.
Medical marijuana is having a moment: as of February 2022, 37 US states permit the use of medical cannabis products. These products are used to treat a variety of medical conditions, from cancer to epilepsy to glaucoma, but specific laws vary by state. And in New York, all dispensaries must have a licensed pharmacist on-site to counsel patients about the treatments available to them. Drug Topics® sat down with Jeff Lombardo, PharmD, to discuss the ins and outs of working in cannabis pharmacy.
Dr. Tanios Bekaii-Saab, MD, leads a discussion with Dr. Kristen Ciombor, MD, MSCI, and Dr. John Strickler, MD, on targeted therapies and the molecular treatment landscape for colorectal cancer. The medical oncologists detail the COLOMATE and GOZILA platforms, sequencing, and resistance to targeted therapies, among other topics.
Ovarian cancer can bring an onslaught of more than a dozen symptoms, as well as lingering anxiety and other difficulties for patients and their caregivers. Heidi Donovan, a professor at the University of Pittsburgh School of Nursing is working with app developer Haomin (Leon) Hu to change that. Their app, which is currently in the early stages of development and is slated to launch next year, will help patients and their caregivers track and manage symptoms, leading to a better feeling of control over the disease.
Charcot-Marie-Tooth (CMT) may be the most common condition involving the peripheral nervous system. However, it's estimated that only 150,000 Americans and 3 million people across the globe live with it, making it a rare disease. In an interview with Giuliana Grossi, Associate Editor, HCPLive, Dr. Keith Fargo discusses some of the challenges in the field and addresses the importance of being cognizant of the blood-nerve barrier when treating patients and developing therapies for CMT.
Eric Segal, MD and Jurriaan Peters, MD, PhD join Second Opinion to go over a case study involving a child with strange spells.
Lori Pierce, MD, highlights reasons for the need of increased diversity within the oncology field.
In this Second Opinion segment, Ehsan Sadri, MD, and William Trattler, MD, share a lively discussion on the advancements that continue to emerge in eye care amid a pandemic. They touch upon the uptick in patient volume and the developing or available treatments for unmet needs, including pharmacologic therapy for presbyopia. Recent innovations from manufacturers are also enhancing the workflow and experience for cataract and refractive surgeons and their patients.
Editors of Managed Healthcare Executive spoke with four healthcare professionals about the relationship between COVID-19 and obesity. The professionals were asked “at what degree is obesity a risk factor for severe COVID-19 and what are the reasons for obesity increasing the risk?” Each gave their individual views on the matter.
On this episode of Deep Dive, Dr Cynthia Otto sits down with dvm360 to discuss the life of a detection dog at the University of Pennsylvania’s Working Dog Center and explains how they train these dogs to smell anything from explosive devices to COVID-19.
On working days, Dr. Michael S. Jellinek is a professor of psychiatry and pediatrics at Harvard Medical School, and Dr. John B. Herman, associate chief of psychiatry at Massachusetts General Hospital, and associate professor of psychiatry at Harvard Medical School. On Saturdays though, the 2 physicians wake up at 6 am, go for an early breakfast at a local restaurant, and then head over to Dr Jellinek’s fully equipped woodshed, situated behind his home in Barre, Massachusetts for a day of woodworking and blacksmithing.
On this Valentine’s Day episode of Inside the Practice, Shyla Pastore and Cherie Scheruich from Absecon Veterinary Hospital explain how they are using this Valentine’s Day to show pets and their owners love while raising money to help pets in need.
In this Wellbeing Checkup episode, ophthalmologist Cathleen M. McCabe, MD, shares some simple hacks for how physicians can incorporate the practice of “three good things” into their daily health routine.
For decades, companies have found ways to raise prices without changing the dollar amount on the price tag. Edgar Dworsky is onto them. Dworsky, a consumer advocate who founded Consumerworld.org, says this product downsizing is a perfect example of shrinkflation. Dworsky sat down with Physicians Financial News to explain the concept, why it matters, and what consumers and businesses can do about it.
Urologist Daniel Shoskes, MD, discusses his passion for early music and, in particular, the lute.
Dr. Jean Talleyrand, Co-Founder and Vice-Chairman of the Clinical Endocannabinoid System Consortium (CESC) and founder of MediCann, joins us to discuss medical cannabis research and ongoing projects he is involved in. As a third generation medical provider, Dr. Talleyrand offers his insight into how medical cannabis can be added as a tool for any doctor to consider.
In this episode of Behind the Science, we hear from optometrists on what they wish they knew when starting out their optometric careers.
Dr. Brennan Spiegel is a beat boxer who recently published a video on twitter of him telling the story of COVID while beatboxing. He has been in tournaments and performed at conferences. Dr. Spiegel talked about how he learned he had this talent and how he does it.
Sandip Patel, MD and Narjust Duma, MD discuss a case scenario of a 45-year-old Hispanic female with lung adenocarcinoma.
On this episode of After Hours, Betsy Charles, DVM, MBA, details her inspiring journey hiking at the 29029 Everesting event in honor of her late husband.
Asteres® chairman and BioIQ CEO, Sean Slovenski joined Inside the Practice to discuss 24/7 automated pharmacy pickup. ScriptCenter allows your pharmacy staff to maintain control of filling and checking prescriptions, while ScriptCenter takes care of the secure storage, tracking, pickup, and payment of your pharmacist-filled prescriptions. Asteres® develops ScriptCenter kiosks and lockers for secure and safe pickup of prescriptions and healthcare products.
Before pursuing a career in pharmacy, Dr. Sonia Oskouei, vice president of Biosimilars at Cardinal Health, played soccer from childhood to high school varsity where she was then asked in her senior year to test her kicking skills as a football placekicker. Sonia discusses her experiences as the kicker for her boys’ high school football team and how key lessons she gained through athletics continue to resonate with her today.
Dr. Rexford Ahima discusses pediatric obesity in the United States and how the pandemic has affected it.
Jack Schim, MD, has been surfing since his boyhood in Miami but found the waves much better in southern California where he went to medical school—and stayed. He uses the word “magical” to describe the sport and says it’s part of the self-care that helps him care for his patients.
Dr. Keipp Talbot discussed with us the currently increasing rate of influenza in the US, as well as the state of research into flu vaccination—a topic which has significant scrutiny right now given the efficacy of COVID-19 vaccines. Among those options for advancing flu vaccines were products designed for older and/or immunocompromised patients, as well as mRNA technology. Additionally, she discussed how, contrary to common belief, flu research may be better informed by sequencing and screening strategies implemented by COVID-19 response—not the other way around.
Dr. Lauren Natbony and Dr. Deena Kuruvilla join Second Opinion to offer a look ahead into heachache medicine in 2022, including what things look like currently, what still needs to be addressed, and what's to come in the future.
Antimicrobial resistance is a paramount concern in medicine. And as it can take many years to develop new antibiotics, alternative therapies are being considered. For example, bacteriophage is a therapeutic platform being used internationally and is emerging her in the United States. Locus Biosciences CEO Paul Garofolo provides an overview of bacteriophage and its potential therapeutic applications.
Now that we have entered our third year of the pandemic, what does life look like going forward? Will COVID-19 be just another virus, alongside influenza and RSV? Will mask-wearing in doctors offices be the new standard, even as we shift out of the pandemic? What about future treatments? Dr. Andrew Schuman, clinical assistant professor of pediatrics at the Geisel School of Medicine at Dartmouth in Lebanon, New Hampshire, and Dr. Russell Libby, founder and president of the Virginia Pediatric Group in Fairfax, Virginia and an assistant clinical professor of pediatrics at the University of Virginia and George Washington University School of medicine, discuss these questions and more, in terms of treating their pediatric patients and talking to their families.
